10/19/2005 5:13:06 PM
CHELMSFORD, Mass.--(BUSINESS WIRE)--March 24, 2005--ESA Biosciences, Inc., a subsidiary of Magellan Biosciences, Inc., announced today that it has been awarded a 'Roadmap Initiative' grant from the National Institutes of Health (NIH) to accelerate ESA's ongoing work in metabolomics research. Under this grant, ESA will extend and integrate electrochemical (EC) and mass spectrometric (MS) technologies to facilitate a range of metabolomics studies. In addition to ESA, twelve leading academic research institutions were awarded metabolomics technology development grants by the NIH.
"We are extremely proud of this award," said Walter DiGiusto, ESA president. "This grant not only validates our company's unique qualifications and accomplishments in commercially developing metabolomics research tools, but it also recognizes the critical importance of metabolomics itself, along side genomics and proteomics, in understanding the complex cellular processes of the human organism."
comments powered by